XML 112 R94.htm IDEA: XBRL DOCUMENT v3.22.4
Long-term Incentive Compensation and Shareholders’ Equity - Summary of Status of Awards Under Stock-Based Compensation Plans and Agreements (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Stock Appreciation Rights (SARs)      
Awards      
Outstanding at beginning of year (in shares) 5,943,000    
Granted (in shares) 130,000    
Exercised/ Vested (in shares) (619,000)    
Canceled (in shares) (64,000)    
Outstanding at end of period (in shares) 5,390,000 5,943,000  
Exercisable at end of period (in shares) 2,618,000    
Weighted-average fair value of grants $ 35.13 $ 32.15 $ 26.70
Weighted average exercise price      
Outstanding at beginning of year (USD per share) 64.66    
Granted (USD per share) 110.63    
Exercised (USD per share) 63.59    
Canceled (USD per share) 55.53    
Outstanding at end of period (USD per share) 66.00 $ 64.66  
Exercisable at end of period (USD per share) $ 64.93    
Weighted average remaining contractual life      
Outstanding at end of period 1 year 7 months 13 days    
Exercisable at end of period 1 year 3 months 25 days    
Stock units      
Awards      
Outstanding at beginning of year (in shares) 3,385,000    
Granted (in shares) 1,152,000    
Added by performance factor (in shares) 136,000    
Exercised/ Vested (in shares) (1,269,000)    
Canceled (in shares) (332,000)    
Outstanding at end of period (in shares) 3,072,000 3,385,000  
Exercisable at end of period (in shares) 0    
Weighted-average fair value of grants (USD per share) $ 107.60 $ 109.50 $ 77.83
Weighted average remaining contractual life      
Outstanding at end of period 1 year 11 months 4 days    
Exercisable at end of period 0 years